ECCR 2019

ECCR 2019: 22nd Meeting of the European Council for  Cardiovascular Research (ECCR) 4 – 6 October 2019 Theme: Hypertension and Cardiometabolic Disease Park Hotel Villa Fiorita – Via Giovannie XXIII, 1 31050 Monastier di Treviso Aims The 22nd Meeting of the ECCR focused on recent advances in hypertension and cardiometabolic disease with an emphasis on translational research from discovery science to human disease. Highlights of the 22nd Meeting

  • The programme included state-of-the art lectures by keynote speakers, training sessions, workshops and abstract sessions with dedicated time for trainees and new investigators.
  • Special awards were given to trainees and fellows
  • There were many social activities and networking opportunities

Programme outline An exciting and comprehensive programme that covered major topics in the field including:

  • Vascular, endocrine and renal mechanisms in hypertension
  • Vascular biology and pathophysiology
  • Vascular aging, senescence and angiogenesis
  • Adipose biology and cardiometabolic disease
  • Vascular-associated systems – lymphatics and the blood brain barrier
  • Obesity, metabolic disorders and cardiovascular disease

Hypertension and cardiometabolic disorders Day 1: 14.30-18.30

14.30-14.45 Welcome and opening
14.45-15.45 Session 1. Mechanistic insights of vascular pathways in hypertension and small vessel disease
14.45-15.15 Overview and objectives of MINDSHIFT
  Thomas Unger, CARIM, Maastricht, The Netherlands  
15.15-15.45 Vascular smooth muscle cell heterogeneity
  Patrick Lacolley, Université de Lorraine, Nancy, France
15.45-16.15 Microglia in cerebral small vessel disease:  impact of hypertension and cardiometabolic disease
  Sebastian Foulquier, Maastricht University, The Netherlands
16.15-16.30 Refreshments
16.30-17.30 Session 2. The renin-angiotensin-aldosterone system revisited
16.30-17.15 3 Abstract presentations
Young investigators
17.15-17.45 Hyperaldosteronism
Gianpaolo Rossi, University of Padua, Italy
17.45-18.15 RAAS profiling in Health and Disease
  Marko Poglitsch, Attoquant Diagnostics GmbH, Vienna, Austria
18.15-18.45 Beyond the classical RAAS
Muscha Steckelings, Odense University, Denmark
19.30 Dinner and fun evening

Day 2: 07.30-18.00

07.30-8.30 Early Career Scientists Workshop I.
  Career planning, networking, grant writing and publishing –everything you wanted to know about succeeding
Rhian Touyz, University of Glasgow, United Kingdom  
08.45-10.15 Session 3. Vessels beyond hypertension
8.45-09.15 Endothelial and vascular smooth muscle genomic instability and cardiovascular disease
  Anton Roks, Erasmus University, Rotterdam, The Netherlands
09.15-09.45 Angiogenesis, VEGF inhibitors and hypertension
  Jan Danser, Erasmus University, Rotterdam, The Netherlands
09.45-10.15 The Contrasting Role of Nox4 and Nox5 in Hypertension
  Augusto Montezano, University of Glasgow, United Kingdom 
10.15-10.45 Refreshments
10.45-16.30 Session 4. Vascular biology and pathophysiology
10.45 11.45 4 Abstract presentations
Young investigators
11.45-12.15 Microvascular dysfunction, hyperglycemia and chronic diseases
  Coen Stehouwer, Maastricht University, The Netherlands
12.15-12.45 An update on estrogen and cardiovascular disease
  Matthius Barton, University of Zurich, Switzerland
13.15-15.30 Lunch and posters
15.30-16.30 Session 4. Vascular biology and pathophysiology (continued)
15.30-16.00 Vascular phenotyping in hypertension- preclinical and clinical
  Christian Delles, University of Glasgow, United Kingdom 
16.00-16.30 Vascular remodeling of resistance arteries in hypertension
  Agostino Virdis, Università di Pisa, Italy
16.30- 17.30 Session 5. Adipose biology and cardiometabolic disease 
16.30-17.00 Perivascular adipose tissue and vascular reactivity
Damiano Rizzoni, University of Brescia, Italy
17.00-17.30 Targeting the renin angiotensin system in cardio-metabolic disease
Ludovit Paulis, Comenius University, Bratislava, Slovakia
19.30 Gala Dinner and fun evening

Day 3: 07.30-13.30


Early Career Scientists Workshop II    
08.45- 10.45 Session 6. Obesity, metabolic disorders and cardiovascular disease- mechanisms and clinical implications
08.45-09.15       Nitric oxide, vascular inflammation and obesity
                            Olga Pechánová, Slovak Academy of Sciences, Bratislava, Slovakia
09.15-09.45 Caloric restriction, oxidative stress and obesity
                            Marta Gill-Ortega University of Madrid, Spain
09.45-10.15 Anorexigenic peptides, obesity and chronic diseases
Lenka Maletinska, Institute of Organic Chemistry and Biochemistry AS CR, Prague, Czech Republic
09.45-10.15 SGL2 inhibitor anti-diabetic drugs and cardiovascular disease
Carmine Savoia, Sapienza University, Italy
10.45-11.15 Refreshments
11.15-13.15 Session 7. Vascular-associated systems: Lymphatics, and the blood brain barrier
11.15-11.45 2 Abstract presentations
  Young investigators
11.45-12.15 Lymphatics, skin and salt homeostasis-new paradigms
  Giacomo Rossitto, University of Padua, Italy
12.15-12.45 Microvascular dysfunction and small vessel disease of the brain
  Boy Houben, Maastricht University, The Netherlands
12.45-13.15 Bone marrow microvascular dysfunction in metabolic disease and ischemia.
  Paolo Madeddu, Bristol Heart Institute, University of Bristol, United Kingdom
13.15-13.30 Closing ceremony and awards
13.30-14.30 Lunch